BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

927 related articles for article (PubMed ID: 32505837)

  • 1. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
    Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
    J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imperatorin alleviates cancer cachexia and prevents muscle wasting via directly inhibiting STAT3.
    Chen L; Xu W; Yang Q; Zhang H; Wan L; Xin B; Zhang J; Guo C
    Pharmacol Res; 2020 Aug; 158():104871. PubMed ID: 32413482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.
    Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE
    J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
    Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
    Castillero E; Alamdari N; Lecker SH; Hasselgren PO
    Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and mice.
    Chen L; Chen L; Wan L; Huo Y; Huang J; Li J; Lu J; Xin B; Yang Q; Guo C
    Oncol Rep; 2019 Aug; 42(2):479-494. PubMed ID: 31233199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective role of pretreatment with Anisodamine against sepsis-induced diaphragm atrophy via inhibiting JAK2/STAT3 pathway.
    Wang Y; Chu Y; Dai H; Zheng Y; Chen R; Zhou C; Zhong Y; Zhan C; Luo J
    Int Immunopharmacol; 2024 May; 133():112133. PubMed ID: 38652962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyropia yezoensis peptide PYP1‑5 protects against dexamethasone‑induced muscle atrophy through the downregulation of atrogin1/MAFbx and MuRF1 in mouse C2C12 myotubes.
    Lee MK; Kim YM; Kim IH; Choi YH; Nam TJ
    Mol Med Rep; 2017 Jun; 15(6):3507-3514. PubMed ID: 28393223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
    Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
    J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
    Reed SA; Sandesara PB; Senf SM; Judge AR
    FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the FoxO1/MuRF1/Atrogin-1 Signaling Pathway in the Oxidative Stress-Induced Atrophy of Cultured Chronic Obstructive Pulmonary Disease Myotubes.
    Pomiès P; Blaquière M; Maury J; Mercier J; Gouzi F; Hayot M
    PLoS One; 2016; 11(8):e0160092. PubMed ID: 27526027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin M induces C2C12 myotube atrophy by modulating muscle differentiation and degradation.
    Miki Y; Morioka T; Shioi A; Fujimoto K; Sakura T; Uedono H; Kakutani Y; Ochi A; Mori K; Shoji T; Emoto M; Inaba M
    Biochem Biophys Res Commun; 2019 Aug; 516(3):951-956. PubMed ID: 31272716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
    Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
    J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RANKL Mediates Muscle Atrophy and Dysfunction in a Cigarette Smoke-induced Model of Chronic Obstructive Pulmonary Disease.
    Xiong J; Le Y; Rao Y; Zhou L; Hu Y; Guo S; Sun Y
    Am J Respir Cell Mol Biol; 2021 May; 64(5):617-628. PubMed ID: 33689672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursolic acid alleviates cancer cachexia by inhibiting STAT3 signaling pathways in C2C12 myotube and CT26 tumor-bearing mouse model.
    Chen L; Chen Y; Wang M; Lai L; Zheng L; Lu H
    Eur J Pharmacol; 2024 Apr; 969():176429. PubMed ID: 38423241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoflavones derived from soy beans prevent MuRF1-mediated muscle atrophy in C2C12 myotubes through SIRT1 activation.
    Hirasaka K; Maeda T; Ikeda C; Haruna M; Kohno S; Abe T; Ochi A; Mukai R; Oarada M; Eshima-Kondo S; Ohno A; Okumura Y; Terao J; Nikawa T
    J Nutr Sci Vitaminol (Tokyo); 2013; 59(4):317-24. PubMed ID: 24064732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
    Seto DN; Kandarian SC; Jackman RW
    J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oleocanthal Protects C2C12 Myotubes against the Pro-Catabolic and Anti-Myogenic Action of Stimuli Able to Induce Muscle Wasting
    De Stefanis D; Balestrini A; Costelli P
    Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saikosaponin D alleviates cancer cachexia by directly inhibiting STAT3.
    Chen LL; Xia LY; Zhang JP; Wang Y; Chen JY; Guo C; Xu WH
    Phytother Res; 2023 Mar; 37(3):809-819. PubMed ID: 36447385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.